Joshua A. Kazam, Partner
Mr. Kazam is a co-founder and Partner of Two River. He currently serves
as Vice President of Two River's managing member and also serves as an
Officer and Director of Riverbank Capital Securities, Inc., a FINRA
member broker dealer ("Riverbank"). Prior to co-founding Two River, he
was employed by a venture capital firm specializing in biotechnology
investments from July of 1999 to September of 2004, where he most
recently served as Managing Director and was responsible for ongoing
operations of venture investments. In addition, Mr. Kazam served as the
Director of Investment Management for the Orion Biomedical Fund, a New
York based private equity fund focused on biotechnology investments.
Mr. Kazam currently serves on the Board of several public companies,
including Nile Therapeutics (Nasdaq: NLTX), Arno Therapeutics
(OTCBB:LRRI.OB), and Velcera, Inc., (OTCBB:VLCR.OB). Mr. Kazam also
currently serves as a director of several privately held companies,
including Tigris Pharmaceuticals and Danube Pharmaceuticals.
Mr. Kazam received his degree in entrepreneurial management from the
Wharton School of the University of Pennsylvania and also currently
serves as an advisor to the
Vagelos Life Sciences program.